4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-075687
Options or other derivatives
- Chief Financial Officer acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Roche Corleen M. Chief Financial Officer | 2025-08-06 | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | D: show line 1 in the form | |||||
| Roche Corleen M. Chief Financial Officer | 2025-08-06 | Grant or award · Restricted Stock Units | +150,000 | 150,000 | D: show line 2 in the form |
Loading xslF345X05/tm2522878-2_4seq1.xml…